ANDERSON ELIZABETH M
SEC CIK 1758247 · EDGAR
BoughtSold
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.11M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-24 18:00 | 2026-09-22 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | M - OptEx | $1.12 | +5,070 | 14.5K | +54% | +$5,678 |
| DMT | 2026-09-24 18:00 | 2026-09-22 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | S - Sale+OE | $193.04 | -10.1K | 4,333 | -70% | -$1.96M |
| D | 2026-06-23 17:45 | 2026-06-18 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +1,191 | 9,406 | +14% | $0 |
| 2026-06-04 18:01 | 2026-06-02 | BMRN | BIOMARIN PHARMACEUTICAL INC | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +7,490 | 41.9K | +22% | $0 | |
| 2026-05-15 16:07 | 2026-05-13 | INSM | INSMED Inc | ANDERSON ELIZABETH M | Dir | A - Grant | — | +3,305 | 62.0K | +6% | — | |
| I | 2026-03-06 | 2026-03-04 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | G - Gift | $0.00 | +15.0K | 15.0K | New | $0 |
| 2026-03-06 | 2026-03-04 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | G - Gift | $0.00 | -15.0K | 8,215 | -65% | $0 | |
| 2025-11-26 | 2025-11-24 | INSM | INSMED Inc | ANDERSON ELIZABETH M | Dir | S - Sale | $204.58 | -5,000 | 58.7K | -8% | -$1.02M | |
| 2025-11-18 | 2025-11-14 | INSM | INSMED Inc | ANDERSON ELIZABETH M | Dir | S - Sale | $195.87 | -10.0K | 63.7K | -14% | -$1.96M | |
| D | 2025-06-30 | 2025-06-26 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +3,142 | 23.2K | +16% | $0 |
| 2025-05-22 | 2025-05-20 | BMRN | BIOMARIN PHARMACEUTICAL INC | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +6,650 | 34.5K | +24% | $0 | |
| 2025-05-19 | 2025-05-15 | INSM | INSMED Inc | ANDERSON ELIZABETH M | Dir | A - Grant | — | +5,058 | 73.7K | +7% | — | |
| DA | 2024-06-28 | 2024-06-20 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +4,248 | 20.1K | +27% | $0 |
| D | 2024-06-24 | 2024-06-20 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +4,800 | 20.6K | +30% | $0 |
| 2024-05-23 | 2024-05-21 | BMRN | BIOMARIN PHARMACEUTICAL INC | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +4,720 | 27.8K | +20% | $0 | |
| 2024-05-15 | 2024-05-13 | INSM | INSMED Inc | ANDERSON ELIZABETH M | Dir | A - Grant | — | +13.2K | 68.7K | +24% | — | |
| D | 2023-06-12 | 2023-06-08 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +5,200 | 15.8K | +49% | $0 |
| 2023-05-24 | 2023-05-23 | BMRN | BIOMARIN PHARMACEUTICAL INC | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +4,190 | 23.1K | +22% | $0 | |
| 2023-05-15 | 2023-05-11 | INSM | INSMED Inc | ANDERSON ELIZABETH M | Dir | A - Grant | — | +13.2K | 55.5K | +31% | — | |
| D | 2022-06-17 | 2022-06-16 | RVMD | Revolution Medicines, Inc. | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +5,200 | 10.6K | +96% | $0 |
| 2022-05-26 | 2022-05-24 | BMRN | BIOMARIN PHARMACEUTICAL INC | ANDERSON ELIZABETH M | Dir | A - Grant | $0.00 | +4,980 | 18.9K | +36% | $0 | |
| 2022-05-13 | 2022-05-11 | INSM | INSMED Inc | ANDERSON ELIZABETH M | Dir | A - Grant | — | +14.6K | 42.3K | +53% | — |
Purchase Sale Sale after option exercise All abbreviations